Skip to content

Metabolism, IEMs, Metabolites, and More

In the field of metabolomics, we owe a lot to A.E. Garrod (pictured on the right).

Who was A.E. Garrod?

In 1909, Archibald Garrod, MD wrote a book, “Inborn Errors of Metabolism” and pioneered the field of “Biochemical Individuality”. 

He is recognized as the "father of biochemistry" by the Royal Society of Medicine.

Inborn-Like Errors of Metabolism (IEMs) are subtle, sub-clinical forms of serious medical illnesses.

From cancer to Covid, diabetes to dementia virtually every disease reflects a state of alerted metabolism. Following the landmark observations of Archibald Garrod who defined Inborn Errors of Metabolism (1909) we find subtle potentially addressable “Inborn-Like” errors of metabolism in the blood of many otherwise healthy patients

Applying these technologies to metabolomic analysis allows a detailed view into the 40 000+ ‘metabolites’, the smallest molecules in human biology, which can reveal biomarkers of disease, particularly cancers, at the very earliest stages of development. At this level of granularity, the way is then open towards truly Personalized Healthcare.

As we age, we manifest disease states that reflect biochemical stresses associated with life-long exposure to “in-born like” errors of metabolism. Stressors from diet, lifestyle, obesity, metabolic syndrome, late pregnancy, or exposure to toxins lead to metabolic re-programming (largely epigenetic) resulting in mal-adaptations that are detectable in the blood at the very earliest stages.

One example of an IEM is Glycogen storage disease. With this, your body isn't able to store sugar from the food you eat which causes low blood sugar.

Another example of an IEM is Hemochromatosis which is a build-up of excess iron levels in your body.

Inborn errors of metabolism (IEMs) can affect anyone since the condition is the result of a genetic change in your DNA.

Our next generation metabolomics platform enables us to detect subtle but clinically significant inborn-like errors of metabolism which offers the opportunity for intervention with individualized recommendations for diet, lifestyle and behavior. 

AE Garrod
Mass Spec with technician

The Power of Targeted Multi-Analyte Mass Spectrometry

Technology has come a long way since A.E. Garrod's time.

Today, our lab technicians process a sample of your blood plasma with our Mass Spectrometer. Then, our medical team, with the help of AI data computation and sophisticated statistical algorithms, generates a report which covers your metabolic processes in key areas of your health.

Harnessing Next Generation Metabolomics for Early Detection and Treatment of Human Disease

Our Metabolomics Solution

Targeted Mass Spectrometry (MS/MS) Testing

Our advanced MS/MS testing platform is designed to identify and quantify metabolic biomarkers associated with Inborn Errors of Metabolism (IEMs). This precise approach allows for early detection of subtle metabolic disturbances, offering insights that are often missed by conventional diagnostics.

Comprehensive IEM Screening

Metabolomycs offers a thorough screening program for over 1,000 known Inborn Errors of Metabolism. Our service enables healthcare providers to detect sub-clinical metabolic disorders, supporting proactive intervention and personalized treatment strategies for patients at risk.

Personalized Disease Management

Leveraging detailed metabolomic data, we empower clinicians to tailor treatment plans based on each patient’s unique metabolic profile. This personalized approach enhances disease management and enables more effective monitoring of therapeutic outcomes.

Contact Us at Metabolomycs

Ready to take a deep dive into your health but still have questions?

Reach out to us about how our Next Generation Metabolomics testing can help you improve your life.

Let's talk!